the hydrogen bound to the carbon of an unlabeled
compound can postsynthetically introduce tritiums into
various compounds with high specific activity.2,4 While
available carrier free T2 gas has extremely high specific
radioactivity and must be handled in a tracer scale, most
of the conventional labeling methods use T2 gas. Conse-
quently, the development of a facile and efficient tritium
labeling method without T2 gas has been desired. Several
H-T exchange reactions in HTO catalyzed by Rh,7 Pt,8
Ru,7b,9 and so on7a,10 have been reported. Especially,
Garnett et al. reported an efficient and pioneering H-T
exchange reaction in HTO catalyzed by platinum black
prepared by the in situ reduction of PtO2 with NaBH4.8
However, the magnitude of the tritium efficiency was
widely varied.
Facile and Efficient Postsynthetic Tritium
Labeling Method Catalyzed by Pd/C
in HTO
Tomohiro Maegawa,† Kosaku Hirota,†
Kenjiro Tatematsu,‡ Yukio Mori,‡ and Hironao Sajiki*,†
Laboratory of Medicinal Chemistry and Laboratory of
Radiochemistry, Gifu Pharmaceutical University, 5-6-1,
Mitahora-higashi, Gifu, 502-8585, Japan
Received August 19, 2005
We have recently disclosed a chemoselective C-H/C-D
exchange reaction on the benzylic carbon in D2O using
Pd/C as a heterogeneous catalyst in the presence of a
catalytic amount of H2 gas at room temperature5 and
multideuterium introduction including the nonactivated
carbon under the heating conditions.6 As an extension
of these methods, we planned to apply them to the H-T
exchange reaction in HTO. In this paper we describe an
efficient and facile H-T exchange reaction catalyzed by
heterogeneous Pd/C in highly diluted HTO as a tritium
source.
We have developed a facile and efficient tritium labeling
method using a Pd/C-HTO-H2 system. This method can
provide multitritium-labeled compounds in highly diluted
HTO under T2 gas-free conditions, and is environmentally
benign since purification by silica gel column chromatogra-
phy is not necessary, which causes a large quantity of
radioactive waste such as silica gel and eluent.
In the deuteration reactions, the use of high-purity D2O
is essential to achieve high deuterium efficiency.5,6 On
the other hand, T2O with high specific activity is highly
Tritium (T) is a most versatile radionuclide and the
detection sensitivity of tritium is roughly a million times
higher than that of deuterium. Organic compounds
labeled with tritiums are widely used in the investigation
for life sciences as an important tracer, such as biosyn-
thetic pathways, analysis of drug metabolism, autorad-
iography, radioassay, and so on.1 While some tritium-
labeled compounds are commercially available, they are
relatively expensive and it is quite difficult to obtain a
desired compound. There are mainly two types of meth-
ods to prepare tritium-labeled organic molecules as
follows: H-T exchange methods2 and reductive synthetic
methods.2,3 The latter reductive methods starting from
a reducible precursor are effective for the incorporation
of tritium atoms onto specific positions with high specific
radioactivity using a stoichiometric amount of tritiated
reducing reagents such as LiBT4 or LiAlT4 and transition
metal-catalyzed reductive dehalogenation and hydroge-
nation using T2 gas. On the other hand, the transition
metal-catalyzed H-T exchange replacement by T2 gas of
(4) Recent reports for H-T exchange reaction with T2 gas catalyzed
by transition metal; (a) Skaddan, M. B.; Yung, C. M.; Bergman, R. G.
Org. Lett. 2004, 6, 11-13. (b) Augustyniak, W.; Kanski, R.; Kanska,
M. J. Labelled Compd. Radiopharm. 2004, 47, 977-981. (c) Salter,
R.; Bosser, I. J. Labelled Compd. Radiopharm. 2003, 46, 489-498. (d)
Shevchenko, V. P.; Nagaev, I. Y.; Myasoedov, N. F. Russ. Chem. Rev.
2003, 72, 423-446.
(5) Sajiki, H.; Hattori, K.; Aoki, F.; Yasunaga, K.; Hitora, K. Synlett
2002, 1149-1151.
(6) (a) Sajiki, H.; Aoki, F.; Esaki, H.; Maegawa, T.; Hirota, K. Org.
Lett. 2004, 6, 1485-1487. (b) Maegawa, T.; Akashi, A.; Esaki, H.; Aoki,
F.; Sajiki, H.; Hirota, K. Synlett 2005, 845-847. (c) Sajiki, H.; Esaki,
H.; Aoki, F.; Maegawa, T.; Hirota, K. Synlett 2005, 1385-1388.
(7) (a) Al-Rawi, J. M. A.; Elvidge, J. A.; Jones, J. R.; Mane, R. B.;
Saieed, M. J. Chem. Res. (S) 1980, 298-299. (b) Hesk, D.; Jones, J. R.
J. Labelled Compd. Radiopharm. 1990, 28, 1427-1436. (c) Hesk, D.;
Jones, J. R.; Lockley, W. J. S. J. Pharm. Sci. 1991, 80, 887-890. (d)
Oohashi, K.; Seki, T. J. Radioanal. Nucl. Chem. 1994, 187, 303-311.
(8) (a) Garnett, J. L.; Long, M. A.; Lukey, C. A. J. Chem. Soc., Chem.
Commun. 1979, 634-635. (b) Garnett, J. L.; Long, M. A.; Lukey, C.
A.; Williams, P. G. J. Chem. Soc., Perkin Trans. 2 1982, 287-289. (c)
Garnett, J. L.; Long, M. A.; Than, C.; Williams, P. G. J. Chem. Soc.,
Faraday Trans. 1990, 86, 875-879. (d) Williams, P. G.; Lukey, C. A.;
Long, M. A.; Garnett, J. L. J. Labelled Compd. Radiopharm. 1990,
29, 175-192. (e) Hesk, D.; Duelfer, T.; Hickey, S.; Hochman, D.;
Koharski, D.; MaNamura, P.; Saluja, S. J. Labelled Compd. Radio-
pharm. 1994, 34, 681-689. (f) Hesk, D.; Bowlen, C.; Hendershot, S.;
Koharski, D.; McNamura, P.; Rettig, D.; Saluja, S. J. Labelled Compd.
Radiopharm. 1996, 38, 1039-1046.
(9) Hesk, D.; Cesarz, D.; Magatti, C.; Voronin, K.; Lavey, C.;
McNamara, P.; Koharski, D.; Saluja, S.; Hendershot, S.; Pham, H.;
Truong, V. J. Labelled Compd. Radiopharm. 2005, 48, 11-23.
(10) (a) Mantescu, C.; Balaban, A. T. Can. J. Chem. 1963, 41, 2120-
2121. (b) Mantescu, C.; Genunche, A.; Balaban, A. T. J. Labelled
Compd. 1965, 1, 178-181. (c) Mantescu, C.; Genunche, A.; Balaban,
A. T. J. Labelled Compd. 1966, 2, 261-266. (d) Mantescu, C.;
Genunche, A.; Duta-Cristu, D.; Balaban, A. T. J. Labelled Compd.
1966, 2, 267-271. (e) Long, M. A.; Garnett, J. L.; Vining, R. F. W.;
Mole, T. J. Am. Chem. Soc. 1972, 94, 8632-8633. (f) Long, M. A.;
Garnett, J. L.; Vining, R. F. W. J. Chem. Soc., Perkin Trans. 2 1975,
1298-1303.
* To whom correspondence should be addressed. Phone: +81-58-
237-3931. Fax: +81-58-237-5979.
† Laboratory of Medicinal Chemistry.
‡ Laboratory of Radiochemistry.
(1) (a) Feinendegen, L. E. Tritium-labeled Molecules in Biology and
Medicine; Academic Press: New York, 1967. (b) Evans, E. A. Tritium
and Its Compounds, 2nd ed.; John Wiley and Sons: London, UK, 1974.
(c) Junk, T.; Catallo, W. J. Chem. Soc. Rev. 1997, 26, 401-406.
(2) Saljoughian, M.; Williams, P. G. Curr. Pharm. Des. 2000, 6,
1029-1056.
(3) (a) Saljoughian, M. Synthesis 2002, 1781-1801. (b) Shevchenko,
V. P.; Nagaev, I. Y.; Myasoedov, N. F. Radiochemistry 2004, 46, 77-
83.
10.1021/jo0517545 CCC: $30.25 © 2005 American Chemical Society
Published on Web 11/08/2005
J. Org. Chem. 2005, 70, 10581-10583
10581